Podcasts about science daily

Ellen goes on a journey through time and space with Triops, the tadpole shrimp. We discuss book fairs, vernal pools, whether saltwater or freshwater came first, trips to space, prehistoric scampi, surprise guests at Burning Man, and so much more. Sources: "Ontogenetic sequence comparison of extant and fossil tadpole shrimps: no support for the “living fossil” concept" - Philipp Wagner et al., Paläontologische Zeitschrift, August 2017 “Survival of dormant organisms after long-term exposure to the space environment” - N. Novikova et al., Acta Astronautica, June 2010 “From antibiotics to yeast: Latest student science heads for space” - NASA, Science Daily, July 2014 “Hundreds of three-eyed 'dinosaur shrimp' emerge after Arizona monsoon” - Laura Geggel, LiveScience, October 2021 “What are the three-eyed ‘dinosaur shrimp' resurfacing after Burning Man?” - Faiza Saqib, The Independent, September 2023 They Might Be Giants song “Triops Has Three Eyes” “Adult Triops cancriformis (Pancrustacea: Notostraca) mediates the hatching rate of its resting eggs” - Alžbeta Devánová et al., Hydrobiologia, March 2022 “Tadpole Shrimp Are Coming for Your Rice” - PBS Deep Look Links: For more information about us & our podcast, head over to our website! Follow Just the Zoo of Us on BlueSky, Facebook, Instagram & Discord! Follow Ellen on Instagram or BlueSky!

Al's on today's proper jaw-dropper: London doctors announce a UK first — a baby born after a womb transplant from a deceased donor. Then it's back to the paperwork side of the future as the government drags Netflix, Prime Video and the rest into tougher Ofcom-style rules. After the break, Uber tries to become the backstage crew for robotaxis everywhere, scientists reveal a new way to see DNA's 3D structure, Fallout 4 goes portable on Switch 2, and Firefox does something radical: it gives you an AI off switch. More on all of it at standard.co.uk — and follow Tech and Science Daily from The Standard for your weekday briefing. Hosted on Acast. See acast.com/privacy for more information.

Al brings you today's Tech and Science Daily from The Standard. We cover a push for a more interventionist UK cyber strategy, new findings on barriers to international digital identity, a quantum photonics milestone involving light drift, early-stage research into an intranasal vaccine approach, and the latest Xbox Game Pass arrivals and departures. Hosted on Acast. See acast.com/privacy for more information.

TfL gets an advert banned by the ASA for reinforcing a harmful stereotype, while the UK moves to force platforms to remove abusive intimate images within 48 hours — or face serious penalties. After the break, we hit the global AI acceleration story, and a proper gaming palate-cleanser with a big Avowed update. More on all of it at standard.co.uk — and follow Tech and Science Daily from The Standard so you're never the last to know. Hosted on Acast. See acast.com/privacy for more information.

Deepfake voice technology is rapidly advancing, but how well do current detection systems handle differences in language and writing style? Most existing work focuses on robustness to acoustic variations such as background noise or compression, while largely overlooking how linguistic variation shapes both deepfake generation and detection. Yet language matters: psycholinguistic features such as sentence structure, complexity, and word choice influence how models synthesize speech, which in turn affects how detectors score and flag audio. In this talk,  we will ask questions such as: "If we change the way a person writes, while keeping their voice the same, will a deepfake detector still reach the same decision?" and "Are some text-to-speech and voice cloning models more vulnerable to shifts in writing style than others?" We will then discuss implications for designing robust deepfake voice detectors and for advancing more trustworthy speech AI in an era of increasingly synthetic media. About the speaker:  Thai Le is an Assistant Professor of Computer Science at the Indiana University's Luddy School of Informatics, Computing, and Engineering. He obtained his doctoral degree from the college of Information Science and Technology at the Pennsylvania State University with an Excellent Research Award and a DAAD Fellowship. His research focuses on the trustworthiness of AI/ML models, with a mission to enhance the robustness, safety, and transparency of AI technology in various sociotechnical contexts. Le has published nearly 50 peer-reviewed research works with two best paper presentation awards. He is a pioneer in collecting and investigating so-called text perturbations in the wild, which has been utilized by users and researchers worldwide to study and understand effects of humans' adversarial behaviors on their daily usage with AI/ML models. His works have also been featured in ScienceDaily, DefenseOne, and Engineering and Technology Magazine.

Recent Cochrane reviews commissioned by the World Health Organization show that blockbuster weight loss drugs like Ozempic deliver substantial results. According to ScienceDaily reporting on February 11, these GLP-1 drugs, including semaglutide in Ozempic and tirzepatide in Mounjaro, lead to average weight losses of 11 to 16 percent over one to two years in people with obesity, far outperforming placebos in trials with thousands of participants. Tirzepatide achieved about 16 percent reduction after 12 to 18 months, while semaglutide hit roughly 11 percent after 24 to 68 weeks, with benefits lasting as long as treatment continues. However, most studies were funded by drugmakers, long-term safety data remain limited, and common side effects like nausea affect many users.A Rutgers Health study published this week in the Journal of Medical Internet Research, as reported by Healthline on February 16, reveals that Ozempic users often prioritize weight loss over these side effects. Researchers analyzed online reviews and found that 67 percent reported reduced appetite and cravings alongside weight loss, making them satisfied enough to continue despite gastrointestinal issues in 62 percent of cases. Lead author Abanoub Armanious noted that everyday users value efficacy highly, even tolerating discomfort that prompts some to stop other treatments. Bariatric surgeon Mir Ali added that patients paying out of pocket show strong motivation, often seeking remedies for nausea rather than quitting.Novo Nordisk announced on February 17 that a new clinical study demonstrated people lost about 21 percent of their body weight on average with their obesity treatment, highlighting ongoing advancements in GLP-1 therapies. No fresh comments from Oprah Winfrey on Ozempic emerged this week, though her past support underscores the cultural buzz around these medications.Experts like Juan Franco from Heinrich Heine University emphasize the excitement after decades without effective options, but call for independent long-term studies on heart health, quality of life, and weight regain after stopping. Access issues persist due to high costs, though semaglutide patents expire this year, potentially lowering prices.Thanks for tuning in, listeners, please subscribe, come back next week for more, and remember this episode was brought to you by Quiet Please podcast networks. For more content like this, please go to Quiet Please dot Ai.Some great Deals https://amzn.to/49SJ3QsFor more check out http://www.quietplease.aiThis content was created in partnership and with the help of Artificial Intelligence AI

Wild animals, Mountain Lions!,  are invading the new world headquarters of the big bank, all the way up to the 70th floor office of Jamie Dimon. The Church of Stop Shopping has provided six bullhorns to project the upsetting screams of the famous apex big cat.  The church services are held at the public garden on Madison Ave, between 47th and 48th, the behemoth buildings ‘back door'.  The largest bank in the world and top investor in fossil fuel, including the four major pipelines in North America, including Israeli weapons…. The screams of the lion will be echoing in the fortress-like Chase HQ, as employees find angry Pumas on their phones and computers, in their minds. Hosted by Reverend Billy and Savitri D, EARTH RIOT is a wild, music-filled exploration of humanity's most urgent issue -- the planet's Sixth Extinction. Made by the Earth-loving urban activists  from The Church of Stop Shopping, this podcast educates, inspires, and urges listeners to embrace reality and take action. Featuring News From the Natural World  a weekly synthesis  of scientific events and reports, , and insightful interviews with radical leaders in environmentalism and activism. Earth Riot Produced by William Talen, Jason Candler and Savitri D Edited by Jason Candler Natural News by Savitri D This show is part of Pantheon Podcasts. Reverend Billy is William Talen. Natural News credits to Mongabay, Phys.org, Science Daily and EHN The Church of Stop Shopping is directed by Savitri D Music by The Stop Shopping Choir  More info: https://revbilly.com/ Substack: https://reverendbillytalen.substack.com/ Patreon: https://www.patreon.com/reverendbilly Bandcamp:  https://revbilly.bandcamp.com/

Have Your Dreams Come True  Millions of us environmentalists are stuck. Big Oil & their banks corrupt whole countries as mass extinction accelerates.   What have we done lately?  Cultivate our self-pitying trance?  NO! - let's be a WOKE MONSTERS FOR THE EARTH. The new 70 story Chase Bank HQ - top climate poisoner - is a fortress. The signal is clear. We can't get in. They live. We die. Let's not throw ourselves against the walls. Let's turn around. GO OUTSIDE!!! The Earth has more much more power than Jamie Dimon. The Earth gives us our vision of change. Something more than hope. Earthalujah! Hosted by Reverend Billy and Savitri D, EARTH RIOT is a wild, music-filled exploration of humanity's most urgent issue -- the planet's Sixth Extinction. Made by the Earth-loving urban activists  from The Church of Stop Shopping, this podcast educates, inspires, and urges listeners to embrace reality and take action. Featuring News From the Natural World  a weekly synthesis  of scientific events and reports, , and insightful interviews with radical leaders in environmentalism and activism. Earth Riot Produced by William Talen, Jason Candler and Savitri D Edited by Jason Candler Natural News by Savitri D This show is part of Pantheon Podcasts. Reverend Billy is William Talen. Natural News credits to Mongabay, Phys.org, Science Daily and EHN The Church of Stop Shopping is directed by Savitri D Music by The Stop Shopping Choir  More info: https://revbilly.com/ Substack: https://reverendbillytalen.substack.com/ Patreon: https://www.patreon.com/reverendbilly Bandcamp:  https://revbilly.bandcamp.com/

Today on Tech and Science Daily from The Standard: the UK sets out new measures aimed at protecting universities from foreign interference, as concerns grow about pressure on researchers and sensitive collaboration. Plus, a record-setting DDoS attack is linked to the AISURU/Kimwolf botnet — a reminder that insecure everyday devices can end up powering serious cyber disruption. And in gaming, Sony confirms a 60+ minute State of Play landing this week, with major updates expected for the PS5 slate. We also look to science, with new research pointing to an empty lava tube beneath Venus, and a fresh method for measuring energy loss in nanoscale systems that could help shape future electronics. Hosted on Acast. See acast.com/privacy for more information.

Novo Nordisk's new drug CagriSema has outperformed Ozempic in a recent Phase III trial for type 2 diabetes patients, according to Clinical Trials Arena. In the REIMAGINE 2 study, CagriSema reduced HbA1c levels by 1.91 percentage points and achieved 14.2 percent weight loss after 68 weeks, compared to 1.76 percentage points and 10.2 percent with Ozempic. No weight loss plateau occurred with CagriSema, and 43 percent of patients lost at least 15 percent of their body weight. Martin Holst Lange, Novo Nordisk's executive vice president and chief scientific officer, stated that combining semaglutide and cagrilintide delivers superior blood glucose control and weight reduction.Researchers are urging a more holistic approach to weight loss amid the Ozempic era, as reported by Medical Xpress on February 3. Experts like Martin Binks and Raedeh Basiri from George Mason University note that GLP-1 drugs such as Ozempic cause rapid weight loss but can lead to nutrient deficiencies, muscle loss, and struggles without proper nutrition, exercise, and psychological support. Many patients receive only prescriptions without multidisciplinary care, and access remains limited by cost and insurance gaps. Binks predicts broader availability with upcoming pill forms.A study highlighted by Science Daily on January 29 warns of rapid weight regain after stopping drugs like Ozempic, with people regaining about 0.4 kilograms per month, often faster than with diet and exercise alone. Heart health and diabetes risk improvements also reverse quickly, emphasizing the need for long-term strategies beyond medication.Oprah Winfrey has shared her experiences with GLP-1 medications, similar to Ozempic, in recent interviews covered by AOL and other outlets. At 71, she regrets not using them sooner, saying they silenced the food noise in her head and helped her view obesity as a disease, not a personal failure. She gained 20 pounds after stopping briefly but now sees these drugs as a lifelong tool, like blood pressure medication, and encourages others without shame.These developments show evolving options and cautions in weight loss treatments. Listeners, thanks for tuning in, please subscribe, and remember, this episode was brought to you by Quiet Please podcast networks. For more content like this, please go to Quiet Please dot Ai. Come back next week for more.Some great Deals https://amzn.to/49SJ3QsFor more check out http://www.quietplease.aiThis content was created in partnership and with the help of Artificial Intelligence AI

Alan Leers is on with your weekday tech-and-science fix from London. Today: a new Imperial-led study asks if Boots and Tesco loyalty card data — from consenting volunteers — could help spot early cancer warning signs sooner. Plus, why handwriting is making a comeback (yes, really), Valheim celebrates five years of Viking chaos, and Notepad++ issues a sobering reminder that software updates need proper security behind them. For more, hit standard.co.uk — and follow Tech and Science Daily so you're never the last to know. Hosted on Acast. See acast.com/privacy for more information.

When we imagine peer pressure, we imagine coming to the rescue by slapping drugs and alcohol out of our kids' hands after their friends undoubtedly tell them they should definitely try some. But peer pressure--who feels it, why, and exactly WHAT kids are being pressured to do--is a complex issue. In this episode, Amy and Margaret discuss: The biological imperative adolescents have to take risks in front of their peers What kids report actually feeling peer pressured to do- the answers aren't what expected How to actually prepare our kids to counter the peer pressure they face This episode was originally released on April 13, 2022. Here are links to past episodes with similar topics: ⁠"When Other Kids Are Bad Influences"⁠ ⁠"What Is Up With Teenagers?"⁠ Here are links to resources mentioned in this episode: Juliana Menasce Horowitz and Nikki Graf for the Pew Research Center: ⁠"Most U.S. Teens See Anxiety and Depression as a Major Problem Among Their Peers"⁠ Centerstone.org: "⁠What is Peer Pressure and Who is at Risk?⁠" Science Daily: ⁠"Peer pressure? It's hardwired into our brains, study finds"⁠ ⁠Laurence Steinberg⁠ and ⁠Kathryn C. Monahan⁠: ⁠Age Differences in Resistance to Peer Influence⁠ Jess Shatkin, ⁠Born to Be Wild: Why Teens Take Risks, and How We Can Help Keep Them Safe⁠ Jessica Lahey, ⁠The Addiction Inoculation: Raising Healthy Kids in a Culture of Dependence⁠ Sign up for What Fresh Hell Plus on Supporting Cast to get all episodes ad-free, plus monthly bonus episodes. Supporting Cast works right where you already listen! Go to whatfreshhell.supportingcast.fm to subscribe in two taps for just $4.99 a month, or $39.99 a year. What Fresh Hell is co-hosted by Amy Wilson and Margaret Ables. We love the sponsors that make this show possible! You can always find all the special deals and codes for all our current sponsors on our website: ⁠⁠⁠https://www.whatfreshhellpodcast.com/p/promo-codes/ What Fresh Hell podcast, mom friends, funny moms, parenting advice, parenting experts, parenting tips, mothers, families, parenting skills, parenting strategies, parenting styles, busy moms, self-help for moms, manage kid's behavior, teenager, tween, child development, family activities, family fun, parent child relationship, decluttering, kid-friendly, invisible workload, default parent, peer pressure Learn more about your ad choices. Visit podcastchoices.com/adchoices

Today, Take a Moment  We honor Dr. King and the loving activists who gave their lives. We hold their lives in memory, as masked men hunt down our neighbors and shoot anyone who argues.  Foreign and domestic security seeks to surveil, track and neutralize people that are in any way righteously moral, funny in the wrong way, or…just… well, different, other.  Great Women and Great Men died for our rights, but now you can be a martyr just by making an ill-advised u-turn or bird watching a bird thats flown into the wrong backyard. Look up at the sky.    Earth Riot Produced by William Talen, Jason Candler and Savitri D Edited by Jason Candler Natural News by Savitri D This show is part of Pantheon Podcasts. Reverend Billy is William Talen. Natural News credits to Mongabay, Phys.org, Science Daily and EHN The Church of Stop Shopping is directed by Savitri D Music by The Stop Shopping Choir  The Fiery Eagles of Justice are Brendan Burke (drums) & Jason Candler (sax) More info: https://revbilly.com/ Substack: https://reverendbillytalen.substack.com/ Patreon: https://www.patreon.com/reverendbilly Bandcamp:  https://revbilly.bandcamp.com/

Today on Tech and Science Daily from The Standard, Alan Leer is on the Tube signal beat as TfL's 4G and 5G rollout in the London Underground reaches the halfway mark. Then we head skyward, with a UCL-led team spotting a strange iron “bar” hidden inside the Ring Nebula.Also on the slate: the BBC is reportedly lining up YouTube-first content to win over younger viewers, RuneScape turns 25 with a wave of player-first changes, and Samsung might've accidentally revealed more than it meant to about the Galaxy S26 lineup. Hosted on Acast. See acast.com/privacy for more information.

Today on Tech and Science Daily from The Standard, Alan Leer coversTfL's ticketing tech getting a major operational change, UCL robots learning to react to sound in real time, and we round up UK robotics policy, AMD's CES reveals, a Final Fantasy VII update, and the latest Android 16 beta fixes. Hosted on Acast. See acast.com/privacy for more information.

Today on Tech and Science Daily from The Standard, London researchers share new findings on how whooping cough vaccination during pregnancy can protect infants at the upper airway, TfL edges closer to regulating pedicabs in 2026, and a UK fusion-focused manufacturing initiative targets a key materials challenge using multi-metal 3D printing. Plus: why flu activity remains elevated in early 2026, a major gaming mod shutdown, and what Apple's iOS 26.3 beta 2 means for iPhone users in Europe. Hosted on Acast. See acast.com/privacy for more information.

Today on Tech and Science Daily from The Standard, former Dragon's Den investor Piers Linney joins Alan Leer to unpack new Tech Show London research on why AI spending is rising in UK business but implementation is lagging — and whether 2026 is make-or-break for the AI boom. Plus, the UK government reportedly rolls back the mandatory element of digital ID right-to-work plans, Animal Crossing: New Horizons drops its free 3.0 update early ahead of a Switch 2 edition launch, and London phone brand Nothing warns that memory chip costs could push smartphone prices higher in 2026. Hosted on Acast. See acast.com/privacy for more information.

Today on Tech and Science Daily from The Standard, Alan Leer covers new UCL brain imaging research separating Parkinson's from Lewy body dementia, an Imperial-linked primate study on bonding behaviours, Which? calling for mandatory front-of-pack nutrition labels in the UK, NASA's early ISS Crew-11 return after a medical issue, plus Star Wars Outlaws landing on Xbox Game Pass and the latest Android security updates. Hosted on Acast. See acast.com/privacy for more information.

Today on Tech and Science Daily from The Standard, Alan Leer covers a London breakthrough from Moorfields and UCL using a routine eye-surgery gel injection to restore sight in rare hypotony cases, plus new UCL Alzheimer's research on APOE gene risk, Brazil's probe into WhatsApp Business terms, Hytale's early access launch and Minecraft's “cutest drop” tease. Plus a little bit for Genshin fans tooYou'll find all your latest news at Standard.co.uk Hosted on Acast. See acast.com/privacy for more information.

Today on Tech and Science Daily from The Standard, we look at fresh plans for a major clinical life sciences building next to St Mary's Hospital in Paddington, TfL's evolving role in how driverless vehicles could operate on London streets, and ARIA's update on real-world field research into “re-thickening” Arctic sea ice. Plus: a London council cyber warning, what Reuters says is coming in the EU's Digital Networks Act, the New Game Plus gaming showcase, and the standout gadgets emerging from CES 2026. Hosted on Acast. See acast.com/privacy for more information.

Ozempic and similar glucagon like peptide 1 medicines remain at the center of the weight loss conversation this week, as new research and renewed celebrity attention highlight both their promise and their limits. According to a January report from the American Society for Metabolic and Bariatric Surgery, scientists reviewing records from more than fifty thousand patients found that people who had bariatric surgery lost about five times more weight over two years than those using weekly glucagon like peptide 1 medicines such as semaglutide, the active ingredient in Ozempic. The analysis, presented at the societys annual scientific meeting and summarized by Science Daily, showed surgery patients averaging roughly fifty eight pounds of weight loss, compared with about twelve pounds for people prescribed Ozempic or related drugs for at least six months. Even among those who stayed on these medicines continuously for a full year, average loss reached only about seven percent of body weight, much lower than the surgical group, underscoring how hard it is for many people to stay on these drugs over time because of cost, side effects, or supply issues. At the same time, obesity specialists quoted this week by Fox News Digital say they expect a major shift in how Ozempic style treatments are used. Rather than being seen only as weight loss shots, doctors are increasingly framing them as whole body metabolic medicines that can lower cardiovascular risk and protect the kidneys and liver, with next generation combinations already in development that may bring greater and more durable weight loss with easier dosing, including daily pills and, in trials, long lasting implants. Against this medical backdrop, Oprah Winfrey continues to shape how many listeners think about Ozempic and weight. In a new People magazine cover story highlighted by AOL in the last few days, she describes her decision to start a glucagon like peptide 1 medicine about two and a half years ago as part of accepting that she lives with the disease of obesity rather than a simple failure of discipline. She explains that understanding obesity as something rooted in genes and biology allowed her to stop blaming herself for decades of weight cycling. Oprah does not name a specific brand in that piece, but she speaks directly to people who see themselves in her story, saying that if obesity runs in your family, it is not your fault and that access to accurate information about medicines, lifestyle changes, and risks should guide decisions, not shame. She also notes that even with medication she still eats carefully and exercises most days, and she expects to remain on a glucagon like peptide 1 treatment long term. For listeners, the message from both the new data and Oprahs comments is that Ozempic and related medicines can be powerful tools, but they are not magic fixes and they work best as part of an ongoing plan that may include surgery, structured exercise, and long term medical follow up. Thanks for listening, please subscribe, and remember this episode was brought to you by Quiet Please podcast networks. For more content like this, please go to Quiet Please dot Ai.Some great Deals https://amzn.to/49SJ3QsFor more check out http://www.quietplease.aiThis content was created in partnership and with the help of Artificial Intelligence AI

Today on Tech and Science Daily from The Standard: London boroughs get a clearer view of EV charge point usage, Imperial-backed dementia studies move forward, and Professor Yves Wiaux explains to Alan Leer how AI is helping create 3D “movies” of black holes. Plus: Xbox sets a Developer_Direct date with Fable and Forza Horizon 6, and CES brings smarter Matter-friendly home tech — and an HP keyboard that's also a full PC. Hosted on Acast. See acast.com/privacy for more information.

Today on Tech and Science Daily from The Standard, our host Alan Leer speaks about London researchers test a self-guided sleep web app for children with epilepsy, the UK piles pressure on X and xAI after Grok image-abuse concerns, and Accenture agrees to acquire London AI firm Faculty. Plus, CES 2026 foldable phone news, a major Valorant update, and the latest Xbox Game Pass additions. For the latest news visit Standard.co.uk Hosted on Acast. See acast.com/privacy for more information.

This week, new research and policy news are reshaping the conversation around Ozempic and other weight loss drugs, while Oprah Winfrey continues to influence how many listeners think about these medications. On the scientific front, a major analysis presented by the American Society for Metabolic and Bariatric Surgery compared real world outcomes for more than fifty thousand people using glucagon like peptide one drugs such as semaglutide, the active ingredient in Ozempic, with those who underwent bariatric surgery. According to ScienceDaily, patients who had gastric bypass or sleeve gastrectomy lost about five times more weight over two years than those using weekly injections, averaging around fifty eight pounds lost with surgery versus about twelve pounds with the drugs. The study also found that many people stop taking medications like Ozempic within a year, limiting long term results and highlighting issues like side effects, costs, and difficulty staying on treatment consistently. At the same time, policymakers are trying to make these drugs easier to afford. The Arkansas Center for Health Improvement reports that the Trump administration has rolled out a new voluntary payment model called Balance, aimed at expanding access to glucagon like peptide one medicines for certain Medicare and Medicaid patients. Under this approach, federal health programs would negotiate lower prices with drug makers and pair coverage with lifestyle and nutrition support. Separate agreements announced earlier with makers of semaglutide and tirzepatide are expected to bring down monthly costs for public programs and some patients over the next few years, though many details and timelines are still evolving. Drug makers are also pushing to expand the ways people can take these medications. Gastroenterology Advisor reports that Novo Nordisk has just launched the first daily oral weight loss pill containing semaglutide nationwide, offering an alternative to injections for those who qualify for medical obesity treatment. For listeners, this means more choices but also more complexity, as they weigh injections versus pills, cost, availability, and how long they will need to stay on therapy. Against this fast moving backdrop, Oprah Winfrey continues to shape public attitudes toward drugs like Ozempic. In recent coverage from outlets such as People Magazine and New Beauty, revisited widely again this week as these new studies and policies emerged, Oprah describes glucagon like peptide one medication as a long term tool rather than a quick fix, saying it helped quiet the constant mental chatter around food and even reduced her desire for alcohol. She has emphasized that she no longer blames herself for decades of weight struggles and instead views obesity as a chronic condition that sometimes requires medical treatment plus healthy habits, not just willpower. Her message, resurfacing in commentary around the latest research, is that these medications can be powerful but work best when combined with lifestyle changes and realistic expectations about how much weight loss they can safely deliver and how long people may need to stay on them. For listeners trying to understand the latest Ozempic headlines, this week underscores three points. Surgery still delivers the biggest and most durable weight loss for severe obesity, new payment and pricing models may slowly improve access to glucagon like peptide one drugs, and high profile voices like Oprah are pushing the conversation toward seeing obesity as a medical disease that may require multiple tools rather than a personal failure. Thanks for listening, please subscribe, and remember—this episode was brought to you by Quiet Please podcast networks. For more content like this, please go to Quiet Please dot Ai.Some great Deals https://amzn.to/49SJ3QsFor more check out http://www.quietplease.aiThis content was created in partnership and with the help of Artificial Intelligence AI

On today's Tech and Science Daily from The Standard, London Councils reviews the Freedom Pass as costs rise, UCL scientists turn brewing waste into scaffolds for cultivated meat, and the UK unveils a new Cyber Action Plan to harden public services. Plus quick consumer security updates and a gaming last call. Find all the latest news at Standard.co.uk Hosted on Acast. See acast.com/privacy for more information.

In today's Tech and Science Daily from The Standard, NHS England sets out priority conditions for its upcoming NHS Online hospital, and CES 2026 kicks off with Intel's new Panther Lake-era laptop chips and fresh Acer ultrabooks. Plus, Arc Raiders confirms “aggression-based matchmaking” that groups PvP-heavy players together. Hosted on Acast. See acast.com/privacy for more information.

Tech and Science Daily from The Standard covers a London council cyber security clampdown after a neighbouring incident, and TfL's plans to modernise Oyster and contactless so phones and wearables play nicer with fare caps. After the break, we're joined by Nesta to talk Future Signals 2026 — the emerging trends that could shape the year ahead — before a quick preview of what to expect from CES in Las Vegas. We also round up the holiday-season gaming hack chatter, with the dramatic TikTok clips versus what's actually been confirmed. For more head to standard.co.uk. Hosted on Acast. See acast.com/privacy for more information.

On this Christmas Eve edition of Tech and Science Daily from The Standard, we're keeping it festive but still very London: Thames Water tackles a fresh Whitechapel fatberg blockage, while Crystal Palace Park's iconic Victorian dinosaur sculptures get a long-overdue restoration glow-up. After the break, we dip into seasonal gaming with Fortnite Winterfest and GTA festive gifts, plus a quick consumer tech check-in for last-minute kit. And in science, we've got a hopeful update on new research reshaping how we think about dopamine and movement in Parkinson's. Head to Standard.co.uk for all the latest Hosted on Acast. See acast.com/privacy for more information.

On today's Tech and Science Daily from The Standard, we look at plans for robotaxi trials in London in 2026, plus the surprising UK science story being dubbed the “year of the octopus” after a boom in sightings and catches off England's south coast. Then Alan Leer drops into an interview with Johannes Maunz, Senior Vice President of AI at Hexagon, on AI-enhanced digital twin mapping — and how virtual city models could help London plan everything from driverless transport to climate-resilient infrastructure and pedestrian-first streets. For more updates, visit standard.co.uk Hosted on Acast. See acast.com/privacy for more information.

On Tech and Science Daily from The Standard, we lead with an extended interview package on claims from former Vodafone franchisees — with 62 ex-partners taking legal action and Vodafone denying wrongdoing. Plus, a London commute upgrade: South Western Railway trials Starlink-powered “super Wi-Fi” on routes in and out of London Waterloo, and we wrap with a quick contactless payments rule change and a free S.T.A.L.K.E.R. 2 content update. For more, visit standard.co.uk. Hosted on Acast. See acast.com/privacy for more information.

Today on Tech and Science Daily from The Standard: the latest on the Westminster and Kensington & Chelsea cyber incident, a quantum year-end update from Imperial and the London Quantum Cluster, and UKRI's shift toward growth funding — including video games. Plus, Revolut's new UK mobile service, Alexa+ arriving on the web, and a couple of practical gaming and headset updates Hosted on Acast. See acast.com/privacy for more information.

Real Life We kick things off with Real Life, where Devon is suspiciously chipper and ahead on billing (don't worry, it doesn't last forever). Steven recounts The Great Lice Infestation of '25, a saga that will echo through the ages—or at least the household laundry room. Ben crowns Sektori as his game of the year, describing it as the best Dreamcast game that never existed and somehow got a remaster. If that sentence alone sells you, here's the deal-tracking rabbit hole via IsThereAnyDeal . Bennnip. Steven also recommends Arc Raiders, a loot-em-up that caught his attention, which leads to a discussion of an AI-related controversy surrounding the game. Ben had heard about it, and we dig into what's actually going on, pulling from this breakdown over at Game Rant: Arc Raiders Gen AI Voice Acting Controversy Explained Back at the table, Steven ran a Mutant Crawl Classics game where a gravitational-lensing mutant plant man absolutely stole the show. As they do. Future or Now Ben brings science to the table with a discussion on tea, coffee, and bone health. He walks us through a decade-long study of older women that found tea drinkers had slightly stronger bones, while moderate coffee consumption caused no harm. Heavy coffee intake—more than five cups a day—was associated with lower bone density, especially when paired with higher alcohol consumption. Tea's benefits may come from catechins that help support bone formation, and the researchers suggest that small daily habits can add up over time. Ben even ran the ScienceDaily article through Google LM to compare it against the original paper. You can read the summary here: Tea may strengthen bones in older women while heavy coffee weakens them Devon tackles a much bigger question: why consciousness exists at all. The research suggests consciousness evolved in layers—starting with basic survival responses like pain and alarm, then expanding into focused awareness and self-reflection. These layers help organisms learn, avoid danger, and coordinate socially. Birds, interestingly, display many of these traits, implying that consciousness may be far older and more widespread than we once thought. The full write-up is worth your time: Why consciousness exists at all Steven had nothing this week, which is honestly its own kind of achievement. Book Club This week's discussion centers on "The Red Thread" by Sofia Samatar, published in Lightspeed Magazine. The story features strong prose, an evocative world, and a compelling narrative voice. Devon respected it but didn't fully connect, while Ben loved it and Steven greatly enjoyed the ride. You can read it here: "The Red Thread" by Sofia Samatar Looking ahead, next week's pick is "The Janitor in Space" by Amber Sparks, which you can find at American Short Fiction: The Janitor in Space — As always, thanks for listening—and remember: drink some tea, question reality, and check your kids for lice.

Ofcom investigates BT's EE and Three after major call outages affected emergency services, plus King's College London research aiming to give robots a sense of touch. We also hear from Pinterest's Sidney Stanback on the Pinterest Predicts 2026 report and how trend forecasting is speeding up, then cover the UK's quantum push with Google's Willow processor, an autonomous spacecraft rendezvous milestone, a UK-backed plan to produce lead-212 radiotherapy isotopes from reprocessed uranium, a warning on budget smartphone pricing pressures in 2026, and a quick gaming performance update from Capcom. For more, visit standard.co.uk. Hosted on Acast. See acast.com/privacy for more information.

In today's episode of Tech and Science Daily from The Standard, we start in London with AI visuals imagining what a six-metre sea level rise could mean for landmarks like Westminster and the Tower of London. Then we break down the Lancet Countdown 2025 findings on climate change and public health, from heat impacts to air pollution, and why it matters for cities like London. Plus, a lighter science story: researchers at Rothera Research Station in Antarctica get a brand-new Royal Mail postbox delivered via the RRS Sir David Attenborough. For more tech and science news, head to standard.co.uk Hosted on Acast. See acast.com/privacy for more information.

Welcome to Ozempic Weightloss Unlocked, the show that unpacks how these medicines are reshaping health, lifestyle, and the science of weight loss.Ozempic is the brand name for semaglutide, a glucagon like peptide one medicine originally approved for type two diabetes that also leads to significant weight reduction. Clinical trials like the STEP program, published in journals such as The New England Journal of Medicine and summarized by the journal Obesity, show average weight loss around fifteen percent of body weight over a little more than a year when combined with lifestyle changes.Real world reports collected by MedShadow describe how some people see dramatic improvements in blood sugar, blood pressure, and joint pain, while others struggle with nausea, constipation, heartburn, or even mood changes. One long term study cited by MedShadow found that people who stopped semaglutide regained about seventy percent of the weight they had lost, highlighting that this often works best as a long term treatment, not a quick fix.According to Rutgers University Camden, most studies so far run only one to two years and show ten to fifteen percent weight loss, but also high discontinuation rates due to side effects or access problems. That raises big questions about sustainability, cost, and what it means for body image to live in an era where powerful appetite changing drugs are widely used.There is also breaking science beyond injectable Ozempic. Advisory Board reports that Novo Nordisk has developed an oral semaglutide pill that produced about sixteen and a half percent weight loss over sixty four weeks, similar to the injection, and has been submitted for approval. Eli Lilly is developing another pill, orforglipron, which led to about twelve percent weight loss in trials without strict food timing rules, making it potentially easier to take.Then there isn't just double, but triple hormone targeting on the horizon. Advisory Board and ABC News describe retatrutide, sometimes called the triple G drug, which mimics three gut hormones. In early trials, people on the highest dose lost around twenty four to almost twenty nine percent of their body weight in about a year to sixteen months, and those with knee arthritis also reported large reductions in pain. These drugs are not yet approved, but multiple large phase three trials are underway.At the same time, researchers in Sweden, writing in the journal Cell and reported by outlets like Fox News and Prevention, are testing a completely different approach, an oral drug sometimes called ATR two five eight that acts more like exercise in a pill. Instead of mainly reducing appetite like Ozempic, it boosts muscle metabolism, improves blood sugar, increases fat burning, and seems to preserve muscle mass, at least in early animal and phase one human studies. If future trials confirm this, it could be combined with glucagon like peptide one drugs to protect muscle while enhancing weight loss.There may even be brain benefits. Science Daily recently covered an analysis suggesting that people with type two diabetes using glucagon like peptide one medicines such as Ozempic, Trulicity, or Victoza were less likely to develop epilepsy, hinting that these drugs might have protective effects in the brain. That research is still emerging, but it adds to ongoing studies on dementia, stroke, and other neurologic conditions.So where does all of this leave you as a listener trying to make sense of the Ozempic era? The evidence shows that semaglutide and related medicines can deliver double digit percentage weight loss, improve blood sugar, and reduce some obesity related risks. But they can cause side effects, are often expensive, and may need to be taken long term to keep the weight off. New pills and next generation drugs promise more convenience, more weight loss, and possibly fewer trade offs like muscle loss, yet they also raise fresh questions about safety, access, and how these medicines will change daily life, from what and how we eat to how we think about our bodies.On future episodes of Ozempic Weightloss Unlocked, we will dive deeper into personal stories, long term safety data, mental health, and practical tips for living well on these medicines, or deciding when they are not the right fit.Thank you for tuning in, and please remember to subscribe so you never miss an update on this fast moving world of Ozempic and weight loss science.This has been a quiet please production, for more check out quiet please dot ai. Some great Deals https://amzn.to/49SJ3QsFor more check out http://www.quietplease.aiThis content was created in partnership and with the help of Artificial Intelligence AI

In this Friday episode of Tech and Science Daily from The Standard, we look at a new UK sound therapy that has reduced tinnitus loudness in trials and could one day be delivered by smartphones. We round up December 2025's biggest new game releases before an interview with Which? editor Harry Rose on their Top 50 products of the year – including that headline-grabbing Asda ketchup ranking. We end on a good-news climate story, as a $24.5m Bezos Earth Fund package moves the world's first cross-border marine biosphere reserve in the eastern Pacific a step closer to reality. Hosted on Acast. See acast.com/privacy for more information.

Real Life We opened this week's episode with real-life updates, starting with Steven's full-on birthday blitz — his birthday, his kids' birthdays, all packed into the same window. There was dinner out, a rowdy round of Ransom Notes, and the proud report that his kid nailed a fully successful sleepover. Parenting achievement unlocked. Devon, meanwhile, came in questioning reality: The Onion is still a newspaper? That somehow turned into a whole debate about debates (1 vs. 20 participants), which feels about right. And then his kid dropped the big question at home: how do we stop an asteroid from hitting Earth? Devon chose the only responsible answer: we "Armageddon" it. Ben ended up on a binge of Home Alone and Hawkeye, which is a surprisingly coherent double feature when you think about it. Future or Now Steven: Why '90s Brains Are Built Differently Steven brought a pair of articles that explore why '90s kids' brains diverged from Gen Z's: a piece from Psychology Zine (link) and a supporting breakdown from Newsweek (link). If you grew up racing Rainbow Road in Mario Kart or discovering secrets in Pokémon Red without a guidebook, you remember when games came in chunky cartridges, had clear endings, and handed out failure like candy. You got better, or you started over. That era hard-coded a very different reward system. Compare that to now: kids juggling Fortnite battle passes, chasing Roblox skins with real money, and fending off constant push notifications baiting FOMO. According to the experts in those articles, this shift isn't just technological — it's actually altering how developing brains handle challenge, reward, and attention. Devon: Can We Finally Trust Quantum Computers? Devon dug into a fascinating breakthrough in quantum computing. Scientists have developed a method that can validate results from quantum computers in minutes instead of millennia. The report came from ScienceDaily (link) and the deeper technical writeup appeared in Quantum Science and Technology (IOP link). Right now, quantum devices — especially GBS machines — are notoriously noisy, and verifying their answers is so computationally hard that we usually just trust whatever they spit out. This new technique already exposed errors in a major earlier experiment, which is both alarming and encouraging. If we want reliable quantum hardware, this is exactly the step we needed. Ben: Giants on the Icelandic Landscape Ben found something visually stunning: a design project that turns routine electrical pylons into towering human-shaped sculptures across Iceland. They're eerie, monumental, and beautiful in a way infrastructure never gets to be. You can see the concept on the designer's site here: choishine.com (link). These pylon-giants use only minor structural tweaks to standard tower design, but the transformation is dramatic. Instead of anonymous metal frames, the landscape gets colossal steel figures marching across the horizon. Book Club This Week: "Dark Air" by Lincoln Michel We read "Dark Air" this week — a moody, unsettling story that mixes environmental dread with strange atmospheric phenomena. You can read it for free on Granta: granta.com/dark-air Next Week: "The Red Thread" by Sofia Samatar Next up is Sofia Samatar's "The Red Thread" — intricate, mythic, and exactly the kind of story we love diving into. You can read it on Lightspeed Magazine: lightspeedmagazine.com/fiction/the-red-thread

On today's Tech and Science Daily from The Standard, we look at NHS warnings over a record “superflu” wave hitting London and what it means for hospitals and daily life in the capital. We break down the 5.8% Tube fare rise coming next March and a new AI carers' support trial in Richmond. After the break, we cover a fresh MIT study on how the brain and immune system team up to keep you in bed when you're sick, PlayStation's 2025 Wrap-Up gaming recap, and Samsung's latest Android XR upgrade for its Galaxy XR headset. For more head to standard.co.uk. Hosted on Acast. See acast.com/privacy for more information.

On today's Tech and Science Daily from The Standard, we're in London for the city's share of a major innovation fund and a Royal Society summit on marine biodiversity, fishing and climate change, with a quick nod to the UK Biobank Scientific Conference in Westminster. We're also joined by Andy Watson, co-founder and CEO of Claimit, to help us understand why lost parcels are costing businesses billions. After the interview, we chat the Geminid meteor shower over London and unpack a new study testing garlic mouthwash against standard antiseptics. For the latest news head to standard.co.uk. Hosted on Acast. See acast.com/privacy for more information.

On today's Tech and Science Daily from The Standard, we break down new TfL lift tech for step-free travel, explain a major UCL study on how air pollution can weaken the benefits of exercise, and look at Cloudflare's latest outage hitting LinkedIn and Zoom. We also cover a huge neutrino collaboration that could explain why the universe exists, December's PlayStation Plus free games and upcoming Game Awards 2025, and Amazon's new Alexa Plus scene-skipping feature for Fire TV. Hosted on Acast. See acast.com/privacy for more information.

In today's episode of Tech and Science Daily from The Standard, we look at a West London GP surgery trialling Mirror, an AI “patient scribe” that helps NHS patients remember their appointments, and the UK's world-first mobile quantum brain scanner designed to study blast effects on troops. We're also joined by Samsung UK & Ireland Chief Customer Officer Deborah Honig to discuss new research on decision fatigue and how AI could ease everyday choices. Plus, we round up December's Xbox Game Pass games, Jorja Smith's AI clone drama, and explain why Android's latest security update is a must-install for your phone. Hosted on Acast. See acast.com/privacy for more information.

In today's Tech and Science Daily from The Standard, we break down the cyber attacks hitting multiple London councils, warnings of a “historic winter crisis” in the capital's A&Es, and a major update to Ordnance Survey's underground mapping project as Openreach joins the National Underground Asset Register.We also take a look at a new UK cyber tool blocking nearly a billion malicious web attempts, hydrogen tech cutting rail maintenance emissions, and a UK-led breakthrough in quantum teleportation between linked networks. Plus, December's first PlayStation Plus game, and YouTube Recap 2025.For all the latest news, head to standard.co.uk. Hosted on Acast. See acast.com/privacy for more information.

Welcome to the O2X limited series Optimizing Parenthood - A Guide to Leading the Next Generation.Over this 5 episode limited series we will explore the science, strategies, and practical wisdom behind raising healthy, confident, and resilient young adults. Hosted by O2X Vice President of Government Brendan Stickles, this podcast brings together leading experts in sleep science, nutrition, fitness, psychology, and personal development to help parents navigate the complexities of modern parenting.Episode #3 features O2X Nutrition Specialist Nick Barringer. Nick currently researches and serves as an assistant professor at the United States Military Academy. Previously while working at the United States Army Research Institute of Environmental Medicine he researched Warfighter nutritional requirements in differing environments to include deployed Special Operators. Prior to that, he taught performance nutrition at the Army-Baylor Graduate Program in Nutrition. Nick served in the 75th Ranger Regiment as a member of the Ranger Athlete Warrior (RAW) program where he oversaw the nutrition and aspects of the physical training of Rangers. He received his undergraduate degree in dietetics from the University of Georgia, his master of science in exercise science from California University of Pennsylvania and his doctorate in kinesiology from Texas A&M. Nick is passionate about improving nutrition and performance in tactical athletes and has the unique perspective of a researcher, teacher, and practitioner who has gone through physically demanding courses such as Ranger School, Survival Evasion Resistance Escape (SERE), Airborne, Air Assault as well as having deployed to both Iraq and Afghanistan so he best understands both the academic and applied demands of the tactical athlete. Nick has presented at both national and international conferences on tactical athlete nutrition and performance and his research has appeared in multiple media outlets such as Science Daily and Men's Journal.Be sure to tune into the following episodes over the following weeks...Episode 1: Dr. Katy Turner on building confidence and resilience within young adults Episode 2: Dr. Jaime Tartar on optimizing sleep schedules for the whole family  Episode 3: Dr. Nick Barringer on developing sustainable and healthy eating habitsEpisode 4: Josh Lamont on creating fitness habits in our youthEpisode 5: Adam La Reau on introducing goal setting and habit building to young adultsBuilding Homes for Heroes:https://www.buildinghomesforheroes.org/Download the O2X Tactical Performance App:app.o2x.comLet us know what you think:Website - http://o2x.comIG - https://instagram.com/o2xhumanperformance?igshid=1kicimx55xt4f 

On today's Tech and Science Daily from The Standard, we break down the UK Government's decision to back Heathrow's third runway plans and speak to UN tourism adviser Anita Mendiratta about what the expansion means for London, the environment and rival European hubs. We also look at how power-hungry data centres are worsening the capital's housing crisis, why Hammersmith & Fulham wants drones to tackle crime, and Uber's new autonomous delivery robots launching in UK cities. Plus, we cover Samsung's Galaxy Z TriFold foldable phone and the biggest gaming releases landing this December.For all the latest news, head to standard.co.uk. Hosted on Acast. See acast.com/privacy for more information.

On today's Tech and Science Daily from The Standard, we look at Puma's massive new Oxford Street flagship store, Stansted and Southend finally joining London's contactless rail network, and how wetter winters are forcing the UK transport system to adapt. We also speak to Tim Johnson from the Civil Aviation Authority about staying safe from Travel Tuesday holiday scams, break down HSBC's new AI partnership with French startup Mistral AI, and run through December's biggest game releases – plus the best Cyber Monday tech deals for Londoners.For all the latest news, head to standard.co.uk. Hosted on Acast. See acast.com/privacy for more information.

On today's Tech and Science Daily from The Standard we explain what the digital phone switchover means for London landline and telecare users, break down how the latest UK Budget plans to keep high-growth tech firms and R&D jobs in Britain, and look at UCL's role in uncovering a vast Bronze Age “mega city”. We also dive into a newly discovered deep-sea hotspot bursting with life, Nintendo's acquisition of Bandai Namco's Singapore studio, and a cosy sci-fi life-sim shadow-dropping into Xbox Game Pass.For all the latest news, head to standard.co.uk. Hosted on Acast. See acast.com/privacy for more information.

This Week on the Pod: Rain, Parades, Hive Minds, and… Ben's Brain for Rent? This week's episode opens with a very rainy round of real-life updates. Ben has been slammed with work and declares—formally, officially, irrevocably—that poetry is better than parades. (He is fully prepared to defend this position.) Meanwhile, Steven reports that the local parade and festival still happened despite the rain, because sometimes community spirit just refuses to check the weather. And Devon? He keeps forgetting that he's technically a Texan now, which raises several questions about residency, identity, and barbecue obligations. But the week wasn't all jokes—Ben also shared the sad news that Orion has passed. He was a very good boy, and the pod raises a collective toast. Ben's been spending time catching up on life, trying to relearn what "rest" even means, and also casually dropping the bomb that Affinity is now free. (Yes, really—go see for yourself at affinity.studio.) And while you're browsing, you can apparently rent Ben's actual mind at Penciledin.com, which sounds like a threat but is, in fact, a service. Steven also let us know that the Fallout Season 2 trailer is out, so it's time to emotionally prepare for more post-apocalyptic chaos.  Future or Now: Tylenol, Autism, and the Psychology of Hive Minds Devon kicks off this segment with actual real science: new research shows no clear link between acetaminophen (Tylenol) and autism, which is a big deal considering how long that concern has been floating around. (Links to ScienceDaily and the BMJ included in the show notes for the skeptics and science nerds.) Then we collectively decide: yes, we need to talk about Plur1bus. And we go deep. This is a full-spoiler discussion, so skip ahead if you're still watching. We cover everything—from the protagonist who's also the antagonist, to the messy moral math of a hive mind, to Devon's incredibly passionate speech about wanting to understand hive-mind psychology. Steven brings up that Internet-as-proto-hivemind theory, and Ben drops several very good points as per tradition. If you want episode breakdowns, the Wikipedia page has everything laid out neatly and also serves as a reminder that this show is way smarter than any of us expected when we hit "play." Book Club (Sort Of) We skipped Book Club this week because there was simply too much Plur1bus to process. Next week: We're reading City Grown From Seed by Diana Dima. Content warning: domestic violence / domestic abuse. You can read it for free on Strange Horizons.

Hey Pickles!We hope you're doing well!Here's what's coming up in today's show!In this week's Y Files, could sunflowers be the future of vegan meats?Here's the article from Science Daily: https://www.sciencedaily.com/releases/2025/11/251104013006.htmIn our Noteworthy segment, Miyoko Schinner is trying to buy back her vegan creamery. We'll update you on the situation.And, in Our Main Topic, we discuss the hidden mental toll on animal farmers.Here's a link to the study: https://bryantresearch.co.uk/insight-items/farmer-mental-health/Our featured Vegan spot in our Assignment Restaurant SOS this week is Not Ya Mama's Vegan Cafe in Salem, Massachusetts.Check out their menu here: https://notyamamascafe.com/menuOf course we have a new Listener Shout Out and more!Thanks so much for listening. Much love, Sam & ChristineSend us a text! We can't respond, but we'd love to hear from you!Support the showJoin Our Patreon https://www.patreon.com/CompassionandcucumbersSign Up For Our Newsletterhttps://www.compassionandcucumbers.comOur YouTube https://www.youtube.com/@compassioncucumbersveganpod/videos72 Reasons To Be Vegan *paid link https://amzn.to/3W8ZwsUVisit Our Website https://www.compassionandcucumbers.comSam's Etsy https://www.etsy.com/shop/CucumberCraftworks

Today, Jenny and Mr. John dig into some new research and more real talk yet again! From optimal resistance training or results to ultraprocessed foods and putting an end to type 1 diabetes, the research is coming in hot! And don;t miss John's Real Talk about education in the fitness fields- it comes in many shapes and ways! Happy listening!References: 1. Comparable Strength and Hypertrophic Adaptations to Low-Load and High-Load Resistance Exercise Training in Trained Individuals: Many Roads Lead to RomeKristoffer Toldnes Cumming, Ingrid Cecelia Elvatun, Richard Kalenius, Gordan Divljak, Truls Raastad, Niklas Psilander, Oscar Horwath bioRxiv 2025.04.28.650925; doi: https://doi.org/10.1101/2025.04.28.6509252. Samuel J. Dicken, Friedrich C. Jassil, Adrian Brown, Monika Kalis, Chloe Stanley, Chaniqua Ranson, Tapiwa Ruwona, Sulmaaz Qamar, Caroline Buck, Ritwika Mallik, Nausheen Hamid, Jonathan M. Bird, Alanna Brown, Benjamin Norton, Claudia A. M. Gandini Wheeler-Kingshott, Mark Hamer, Chris van Tulleken, Kevin D. Hall, Abigail Fisher, Janine Makaronidis, Rachel L. Batterham. Ultraprocessed or minimally processed diets following healthy dietary guidelines on weight and cardiometabolic health: a randomized, crossover trial. Nature Medicine, 2025; DOI: 10.1038/s41591-025-03842-03. Mayo Clinic. "This sugar molecule could stop type 1 diabetes, by fooling the immune system." ScienceDaily. www.sciencedaily.com/releases/2025/08/250802022917.htm (accessed August 2, 2025).

Welcome to the Refill! Refilling your mind with the latest in mental health and Pharmacy news.This is a new channel (and podcast segment), designed to bring you the latest insights and news in the world of mental health and pharmacy. If you want more tips and conversations about mindfulness, and mental health checkout The Mindful PharmD Podcast on major podcast platforms.Connect with me --> https://drmatmonharrell.bio.link/Music provided by PodcastleReferencesThe Hebrew University of Jerusalem. Popular hair-loss pill linked to depression and suicide. ScienceDaily. October 13, 2025. Available from: https://www.sciencedaily.com/releases/2025/10/251013040343.htmUnknown Author. (2025). Simple screening tool could save a patient's life. Doximity. https://www.doximity.com/articles/7e2b43ef-176d-44ac-ad43-1b857e092232Kansteiner F. With FDA nod, Bayer's Lynkuet enters US market for nonhormonal menopause symptom meds. FiercePharma. October 24, 2025. Available from: https://www.fiercepharma.com/pharma/fda-nod-bayers-lynkuet-enters-limited-us-market-nonhormonal-menopause-symptom-meds Vincent, E. & Vincent, B. (2025, October 20). Instagram shows more ‘eating disorder-adjacent' content to vulnerable teens, internal Meta research shows. Reuters. https://www.reuters.com/business/instagram-shows-more-eating-disorder-adjacent-content-vulnerable-teens-internal-2025-10-20/ Subscribe. Share. Rate.A thousand thanks!drmatmonharrell.bio.link Hosted on Acast. See acast.com/privacy for more information.